Reference
- Balato N, Patruno C, Napolitano M, et al. Managing moderate-to-severe psoriasis in the elderly. Drugs Aging. 2014;31(4):233–238.
- Grozdev IS, Van Voorhees AS, Gottlieb AB, et al. Psoriasis in the elderly: from the medical board of the national psoriasis foundation. J Am Acad Dermatol. 2011;65(3):537–545.
- Boots AM, Maier AB, Stinissen P, et al. The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol. 2013;9(10):604–613.
- Rowietz U, Altmeyer P, Bieber T, et al. Treatment of psoriasis with fumaric acid esters (fumaderm). J Dtsch Dermatol Ges. 2007;5(8):716–717.
- Reich K, Thaci D, Mrowietz U, et al. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis-a retrospective study (FUTURE). J Dtsch Dermatol Ges. 2009;7(7):603–610.
- Nast A, Gisondi P, Ormerod AD, et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris-Update 2015-Short version-EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015;29(12):2277–2294.
- Available at: www.who.int/healthinfo/survey/ageingdefnolder/en
- Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;2:1–70.
- Zweegers J, de Jong EM, Nijsten TE, et al. Summary of the dutch S3-guidelines on the treatment of psoriasis 2011. Dutch society of dermatology and venereology. Dermatol Online J. 2014;20:doj_21769.
- European Medicines Agency. Skilarence, INN-dimethyl fumarate: Summary of Product Characteristics. European Medicines Agency, London, 2017.
- Thaci D, Weisenseel P, Philipp S, et al. Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions – a retrospective evaluation (FACTS). J Dtsch Dermatol Ges. 2013;11(5):429–435.
- Kratzsch D, Treudler R. Dermatologic therapy in geriatric patients. J Dtsch Dermatol Ges. 2014;12(8):653–663.
- Hoefnagel JJ, Thio HB, Willemze R, et al. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol. 2003;149(2):363–369.
- Wain EM, Darling MI, Pleass RD, et al. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study. Br J Dermatol. 2010;162(2):427–434.
- Lijnen R, Otters E, Balak D, et al. Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study. J Dermatol Treat. 2015;19:1–6.